/
CHJTF
$0.98-$0.07 (-6.73%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.94 – $1.39
8% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-0.22
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.03B | $22.08B | $24.92B | $27.90B | $30.94B | $34.60B | $28.99B | $25.33B |
| Cost of revenue | $6.81B | $6.18B | $6.26B | $6.73B | $8.86B | $10.20B | $8.71B | $8.71B |
| Gross profit | $13.36B | $15.89B | $18.69B | $21.14B | $22.73B | $24.40B | $20.29B | $16.61B |
| Gross margin | 63.5% | 72.0% | 75.0% | 75.8% | 73.5% | 70.5% | 70.0% | 65.6% |
| R&D | $1.58B | $2.00B | $2.89B | $3.44B | $4.58B | $5.34B | $5.19B | $5.66B |
| Operating income | $4.35B | $4.60B | $5.46B | $6.25B | $6.92B | $7.68B | $5.45B | $3.87B |
| EBITDA | $5.32B | $4.71B | $5.90B | $6.98B | $8.66B | $8.53B | $6.45B | $5.24B |
| Net income | $3.51B | $3.71B | $4.34B | $5.61B | $6.21B | $5.87B | $4.33B | $3.78B |
| Net margin | 16.7% | 16.8% | 17.4% | 20.1% | 20.1% | 17.0% | 14.9% | 14.9% |
| EPS (diluted) | 0.31 | 0.31 | 0.36 | 0.47 | 0.52 | 0.49 | 0.37 | 0.33 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $36.0B | $0.75 | $0.58–$1.00 | 1 |
| 2027 | $35.4B | $0.61 | $0.47–$0.81 | 1 |
| 2028 | $37.7B | $0.66 | $0.51–$0.87 | 1 |
| 2029 | $45.5B | $0.95 | $0.73–$1.26 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.67
Price
$0.98
Implied downside
-31%
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CHJTFCSPC Pharmaceutical Group Limited | $0.98 | +0.00% | $11.2B | — |
| ALBBYAlibaba Health Information Technology Limited | $8.46 | +6.82% | $6.8B | — |
| BDUUYBangkok Dusit Medical Services Public Company Limited | $23.41 | +0.00% | $9.3B | — |
| BIOVFSwedish Orphan Biovitrum AB (publ) | $48.00 | +0.00% | $16.6B | — |
| ERFSFEurofins Scientific SE |
CSPC PHARM GROUP LTD ORD
CSPC PHARM GROUP LTD ORD
Held by traders on TradeandTell
No one on the platform currently holds CHJTF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CHJTF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 56.16% ($0.55/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-26 | $0.1500 | 2026-07-15 |
| 2025-10-21 | $0.1400 | 2025-11-18 |
| 2025-06-06 | $0.1000 | 2025-07-18 |
| 2024-11-04 | $0.1600 | 2024-11-20 |
| 2024-06-04 | $0.1400 | 2024-06-26 |
| 2023-09-08 | $0.1400 | 2023-10-12 |
Recent trades on TradeandTell
No one on the platform has traded CHJTF yet.